The study, titled “A Large-Scale Efficacy Trial of a Resilience Training Program for First Responders,” will enroll 800 first responders in New York and Texas
New filling line approval supports delivery of integrated, end-to-end solutions across the entire biologics and bioconjugates value chain
Ranibizumab is a recombinant humanized IgG1 monoclonal antibody fragment that binds to and inhibits vascular endothelial growth factor A
Glenmark acquired the ANDA for Acetylcysteine Injection, 6 gm/30 mL (200 mg/mL) Single-Dose Vials from Aspen Pharma USA
Steinberg brings nearly three decades of experience in biopharmaceutical equity research to Prolacta's executive team.
Dr. Bernstein will tap into her decades of leadership and strategy experience as she transitions into this new role at APhA
WCK 5222 is the first New Chemical Entity (NCE) discovered and developed in India to be submitted for pan-European marketing authorisation
Under the agreement, AVT06 is licensed to enter the US market in the fourth quarter of 2026
WINREVAIR is currently the first and only activin signalling inhibitor approved for PAH across all 27 EU member states
LNK01006 is designed to deliver potent, selective inhibition of TYK2-mediated cytokine signaling with central nervous system exposure
Subscribe To Our Newsletter & Stay Updated
